Amyloid peptides in different assembly states and related effects on isolated and cellular proteasomes

Brain Research

Volumn 1209, Issue , 2008, Pages 8-18

  Cecarini, Valentina ^a   Bonfili, Laura ^a   Amici, Manila ^a   Angeletti, Mauro ^a   Keller, Jeffrey N ^b   Eleuteri, Anna Maria ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Alzheimer's disease; Amyloid peptides; Oxidation; Proteasome

Indexed keywords

20S PROTEASOME; AMYLOID BETA PROTEIN; PROTEASOME; PROTEIN P27; UBIQUITIN;

ALZHEIMER DISEASE; ARTICLE; CANCER CELL CULTURE; CELL LYSATE; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVE SITE; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PURIFICATION;

EID: 42749092968     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.03.003     Document Type: Article

References (46)

1. Almenoff J.,Orlowski M.Membrane-bound kidney neutral metalloendopeptidase: interaction with synthetic substrates,natural peptides, and inhibitors. Biochemistry 22(3),1983,pp:590–599.
2. Amici M.,Lupidi G.,Angeletti M.,Fioretti E.,Eleuteri A.M.Peroxynitrite-induced oxidation and its effects on isolated proteasomal systems.Free Radical Biology and Medicine. 34(3),2003,pp:987–996.
3. Bradford, M.M.. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Analytical Biochemistry. 72,1976.pp:248–254.
4. Butterfield, D.A., 2002. Amyloid beta-peptide (1–42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. FreeRadic. Res. 36, 1307–1313.
5. Butterfield, D.A., Reed, T., Newman, S.F., Sultana, R.. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.Free Radical Biology and Medicine. 43(5),2007,pp:658–677.
6. Caughey, B., Lansbury, P.T., 2003. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.Annual Review of Neuroscience. 26,2003.pp:267–298.
7. Cecarini, V., Ding, Q., Keller, J.N., 2007. Oxidative inactivation of the proteasome in Alzheimer's disease.Free Radical Research. 41(6), 673–680.
8. Cecchi, C., Fiorillo,C., Baglioni, S., Pensalfini,A., Bagnoli, S.,Nacmias B., Sorbi, S., Nosi, D., Relini, A., Liguri, G., 2007. Increased susceptibility to amyloid toxicity in familial Alzheimer's fibroblasts.Neurobiology of Aging 28(6),pp:863–876.
9. Dahlgren, K.N., Manelli, A.M., Stine Jr., W.B., Baker, L.K., Krafft, G.A.,LaDu, M.J., 2002. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. Journal of Biological Chemistry. 277, 32046–32053.
10. Ding, Q., Dimayuga, E., Keller, J.N., 2007. Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease.Current Alzheimer Research. 4(1), 73–79.
11. Eleuteri, A.M., Kohanski, R.A., Cardozo, C., Orlowski, M., 1997.Bovine spleen multicatalytic proteinase complex (proteasome).Replacement of X, Y, and Z subunits by LMP7, LMP2, and MECL1and changes in properties and specificity.Journal of Biological Chemistry. 272(18),11824–11831.
12. Eleuteri A.M., Angeletti M., Lupidi G., Tacconi R., Bini L., Fioretti E.Isolation and characterization of bovine thymus multicatalytic proteinase complex.Protein Expression and Purification. 18(2),2000, pp. 160-168
13. Evans, C.G., Wisen, S., Gestwicki, J.E., 2006. Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1–42) aggregation in vitro.Journal of Biological Chemistry.281, 33182–33191.
14. Fenteany, G., Standaert, R.F., Lane, W.S., Choi, S., Corey, E.J.,Schreiber, S.L., 1995.Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification bylactacystin. Science 268, 726–731.
15. Gregori, L., Fuchs, C., Figueiredo-Pereira, M.E., Van Nostrand, W.E.,Goldgaber, D., 1995. Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro. J. Biol. Chem.270, 19702–19708.
16. Gregori, L., Hainfeld, J.F., Simon, M.N., Goldgaber, D., 1997. Binding of amyloid beta protein to the 20 S proteasome. J. Biol. Chem. 272, 58–62.
17. Gregori, L., Hainfeld, J.F., Simon, M.N., Goldgaber, D., 1997. Binding of amyloid beta protein to the 20 S proteasome. J. Biol. Chem. 272, 58–62.
18. Grune, T., Merker, K., Sandig, G., Davies, K.J., 2003. Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem. Biophys. Res. Commun. 305, 709–718.
19. Holtsberg, F.W., Steiner, M.R., Keller, J.N., Mark, R.J., Mattson, M.P., Steiner, S.M., 1998. Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons. J. Neurochem. 70, 66–76.
20. Keck, S., Nitsch, R., Grune, T., Ullrich, O., 2003. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.Journal of Neurochemistry. 85(1), 115–122.
21. Keller, J.N., 2006. Age-related neuropathology, cognitive decline, and Alzheimer's disease. Ageing Res. Rev. 5, 1–13.
22. Keller, J.N., Markesbery, W.R., 2000. Proteasome inhibition results in increased poly-ADP-ribosylation: implications for neuron death. J. Neurosci. Res. 61, 436–442.
23. Keller, J.N., Markesbery, W.R., 2000. Proteasome inhibition results in increased poly-ADP-ribosylation: implications for neuron death. J. Neurosci. Res. 61, 436–442.
24. Keller, J.N.,Hanni,K.B.,Markesbery,W.R., 2000. Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436–439.
25. Keller, J.N., Schmitt, F.A., Scheff, S.W., Ding, Q., Chen, Q.,Butterfield, D.A., Markesbery, W.R., 2005. Evidence of increased oxidative damage in subjects with mild cognitive impairment.Neurology 64, 1152–1156.
26. Lambert, M.P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R.,Liosatos, M., Morgan, T.E., Rozovsky, I., Trommer, B., Viola, K.L.,Wals, P., Zhang, C., Finch, C.E., Krafft, G.A., Klein, W.L., 1998.Diffusible, nonfibrillar ligands derived from Abeta1–42 arepotent central nervous system neurotoxins. Proc. Natl. Acad.Sci. U. S. A. 95, 6448–6453.
27. LeVine III, H., 1999. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309, 274–284.
28. Lopez Salon, M., Morelli, L., Castano, E.M., Soto, E.F., Pasquini, J.M.,2000.Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 62, 302–310.
29. Lopez Salon, M., Pasquini, L., Besio Moreno, M., Pasquini, J.M., Soto,E., 2003. Relationship between beta-amyloid degradation andthe 26S proteasome in neural cells. Exp. Neurol. 180, 131–143.
30. Marchini, C., Angeletti, M., Eleuteri, A.M., Fedeli, A., Fioretti, E.,2005. Aspirin modulates LPS-induced nitric oxide release in ratglial cells. Neurosci. Lett. 381, 86–91.
31. Mosmann, T., 1983. Rapid colorimetric assay for cellular growthand survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63.
32. Nagele, R.G., D'Andrea, M.R., Anderson, W.J., Wang, H.Y., 2002.Intracellular accumulation of beta-amyloid(1–42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110, 199–211.
33. Oh, S., Hong, H.S., Hwang, E., Sim, H.J., Lee, W., Shin, S.J.,Mook-Jung,I., 2005. Amyloid peptide attenuates the proteasome activity in neuronal cells. Mech. Ageing Dev. 126, 1292–1299.
34. Orlowski, M., Michaud, C., 1989. Pituitary multicatalytic proteinase complex. Specificity of components and aspects of proteolytic activity. Biochemistry 28, 9270–9278.
35. Orlowski, M.,Wilk, S., 2000. Catalytic activities of the 20 S proteasome, amulticatalytic proteinase complex. Arch.Biochem. Biophys. 383, 1–16.
36. Orlowski, M., Cardozo, C., Michaud, C., 1993. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 32, 1563–1572.
37. Pagano, M., Tam, S.W., Theodoras, A.M., Beer-Romero, P., Del Sal,G., Chau, V., Yew, P.R., Draetta, G.F., Rolfe, M., 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682–685.
38. Pfleiderer, G., 1970. Isolation of an aminopetidase from kidney particles. In: Perlman, G.E., Lorand, L. (Eds.), Methods in Enzymology. Particle-bound aminopeptidase from pig kidney, vol. 19. Academic press, pp. 514–521.
39. Poppek, D., Grune, T., 2006. Proteasomal defense of oxidative protein modifications. Antioxid. Redox Signal. 8, 173–184.
40. Poppek, D., Grune, T., 2006. Proteasomal defense of oxidative protein modifications. Antioxid. Redox Signal. 8, 173–184.
41. Saavedra, L., Mohamed, A., Ma, V., Kar, S., de Chaves, E.P., 2007. Internalization of beta-amyloid peptide by primary neurons in the absence of apolipoprotein E. J. Biol. Chem. 282,35722–35732.
42. Selkoe, D.J., 2001. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741–766.
43. Smith, D.G., Cappai, R., Barnham, K.J., 2007. The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim. Biophys. Acta 1768, 1976–1990.
44. Vinitsky, A., Cardozo, C., Sepp-Lorenzino, L., Michaud, C., Orlowski,M., 1994. Inhibitionof the proteolytic activity of themulticatalytic proteinase complex (proteasome) by substrate-related peptidyl aldehydes. J. Biol. Chem. 269, 29860–29866.
45. Wilk, S., Orlowski, M., 1983. Evidence that pituitary cation-sensitive neutral endopeptidase is a multicatalytic protease complex. J. Neurochem. 40, 842–849.
46. Zhu, X., Raina, A.K., Lee, H.G., Casadesus, G., Smith, M.A., Perry, G.,2004. Oxidative stress signalling in Alzheimer's disease. Brain Res. 1000, 32–39.